Leanne Kelly
CIK: 0001398278
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 18, 2025GRI
GRI Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
43.2K shares- - Aug 26, 2025GRI
GRI Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
11.9K shares- - Jan 23, 2025GRI
GRI Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
43.3K shares at avg. $0.69-
1-3 of 3 transactions
About Kelly Leanne
Kelly Leanne (SEC CIK 0001398278) files insider reports with the SEC as Chief Financial Officer of GRI Bio, Inc. (GRI) and Director of WINDTREE THERAPEUTICS INC /DE/ (WINT).
Signal8 holds 4 ownership filings by Kelly Leanne (1 Form 3, 3 Form 4), filed between Jan 14, 2025 and Sep 22, 2025. Those filings report 3 transactions, from Jan 23, 2025 to Sep 18, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Kelly Leanne's filings is in LA JOLLA, CA.
Recent filings by Kelly Leanne
Other insiders filing for GRI Bio, Inc. (GRI)
- Szekeres David Leslie, Director
- Baker David Charles, Director
- SIMPSON CAMILLA V, Director
- Chaturvedi Vipin, Chief Scientific Officer
- Rongen Roelof, Director
- Hertz Walter Marc, Chief Executive Officer